3 Top Stock Picks for 2021
After banner returns in 2020 despite it being a stock picker's market, here are our three top stock picks for 2021.
Read More
chris temple Archives
Sarepta Therapeutics—A Lot is Riding on the FDA Decision
By Chris Temple of The National Investor
Wall Street’s Best Investments Editor’s Note: An FDA panel has not yet given its seal of approval to Sarepta Therapeutics new muscular dystrophy drug—the final FDA hearing is scheduled for the end of May. Meanwhile, Chris Temple us...
Read More
Top Stocks to Buy this Year
Every year, I ask our contributors to Wall Street’s Best Dividend Stocks and Wall Street’s Best Investments to select the one investment that they believe will be their biggest winner that year. And earlier this month, I published the winners in our special Picks...
Read More
Wall Street’s Best Dividend Stocks Top Picks 2015
While two of the three broad market indices fell on hard times in 2015, the top four recommendations in our 2015 Top Picks issue gave subscribers some excellent gains! For the year, the Dow Jones Industrial Average lost -2.24%, the S&P 500 was -0.73%...
Read More
Universal Health Realty Income Trust (UHT)
In today’s Daily Alert, Chris Temple recommends a specialized REIT with a 6% yield, and David Dittman provides an update on one of his MLPs.
Universal Health Realty Income Trust (UHT)
from The National Investor
Universal Health REIT (UHT), an owner of more than 50 facilities 15...
Read More
Annaly Capital Management, Inc. (NLY)
In today’s Daily Alert The National Investor Editor Chris Temple recommends a value-priced mortgage REIT currently yielding a whopping 13.3%.
“Annaly Capital Management, Inc. (NLY, NYSE) is one of the largest and best known names among mortgage-related real estate investment trusts (REITs). But it been...
Read More
Sarepta Therapeutics (SRPT)
April 25 Investment Digest Daily Alert
I hope you’re enjoying yesterday’s new Investment Digest issue. Today’s Daily Alert
brings a follow-up on a low-priced pharmaceutical company recommended in
the Digest in past years. Below, Chris Temple says it’s time to take profits on his
wildly successful recommendation.
Sell Sarepta...
Read More
Sell Alert: SuperValu, Inc. (SVU)
Giving up on and selling stocks that don’t work out is one of the hardest parts of investing for many of our subscribers. But it’s one of the most important parts too. In today’s Daily Alert, The National Investor Editor Chris Temple explains it’s...
Read More
Stock Market Crash Course: Medium-Term Trouble
In today's Stock Market Crash Course, the experts say the market still looks strong, but there are some signs things are deteriorating under the surface. Volume, the VIX and stocks making new highs are all suggesting a correction ahead. Experts quoted include Stephen Rick...
Read More